Patients must be told what home infusion costs them
What the document says“The Secretary of Health and Human Services shall ensure that patients are notified of the cost sharing for electing home infusion therapy compared to other applicable settings of care for the furnishing of infusion drugs under the Medicare program.”
Subsection (b) of section 6222 requires the Secretary of Health and Human Services to ensure that patients are told what cost sharing applies if they choose home infusion therapy, set against what applies in other settings of care.
What the document actually says“The Secretary of Health and Human Services shall ensure that patients are notified of the cost sharing for electing home infusion therapy compared to other applicable settings of care for the furnishing of infusion drugs under the Medicare program.”
The health chief must make sure patients are told what home care costs them. The cost is set next to what other places would cost.
Cost sharing is the part a patient pays. The same drug can cost different amounts in different places. A patient choosing needs to know that.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.